Gene & Cell Technology – VGCT

INTRODUCTION

Vietnam Gene & Cell Technology Joint Stock Company was established in 2018 and is a member company of the CT Group with over 30 years of experience in the development of cell and gene technology, as well as high-tech technologies from abroad.

The company was founded by a group of doctors and biomedical Ph.D. holders, who have studied abroad, sharing a passion and ambition for research, development, application, and production of therapeutic products derived from gene and cell technologies for patients in Vietnam and the Asia region.

The professional team consists of a combination of Medical Team – Biologists & Scientists – Commercial Team.

Exclusive technology transfer agreements with Israel, Korea, Japan, and Finland.

Treatment consultations are provided by Vietnamese doctors, with direct therapy from foreign medical specialists.

COMMITMENT

VGCT is committed to enhancing the quality of life for the community and ensuring the best possible health for everyone.

VGCT’s goal is to become a leading company in the production of cell and gene technology in Asia and to develop the most advanced high-tech therapeutic products for application in health sciences and agriculture.

SERVICES